Renovos is transforming regenerative medicine through pioneering use of RENOVITE® nanoclay gels, stemming from world-class stem cell research. RENOVITE® formulations are injectable, bioactive, and can deliver and retain biologics within the target site of repair, allowing for dose reduction, lower COGS and improved safety of potent biologics. Renovos’ mission is to unlock the full potential of regenerative medicine and help clinicians deliver safe and more efficacious treatments for tissue repair, addressing a $5bn orthobiologics market. Renovos has granted patents and a strong scientific and commercial team. The company is now raising funding to complete pre-clinical development and enable clinical trials.
